## JPM: JPMorgan Chase & Co. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.9% below STRENGTH zone (3.0-6.0%); PEG 2.78 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($322.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Guarantor: JPMorgan Chase & Co.**
- Source: StreetInsider | 20260106T194653 | Neutral | Relevance: 100%
- JPMorgan Chase Financial Company LLC has issued $1,681,000 in Uncapped Digital Barrier Notes, fully and unconditionally guaranteed by JPMorgan Chase & Co. These notes are linked to the performance of the Dow Jones Industrial Average, Russell 2000 Index, and S&P 500 Index, offering investors uncapped appreciation exposure with a contingent minimum return of 51.50%. Investors should be aware of risks including potential principal loss and credit risks associated with both JPMorgan Financial and JPMorgan Chase & Co.

**2. JPMorgan Chase & Co. (JPM) Reports Next Week: Wall Street Expects Earnings Growth**
- Source: Finviz | 20260106T162101 | Bullish | Relevance: 100%
- JPMorgan Chase & Co. (JPM) is expected to report an increase in earnings and higher revenues for the quarter ended December 2025. The company's Earnings ESP of +1.41% combined with a Zacks Rank of #3 suggests a high probability of beating the consensus EPS estimate of $4.97 per share. Historically, JPMorgan Chase & Co. has beaten consensus EPS estimates in the last four quarters.

**3. JPMorgan Chase & Co. (NYSE:JPM) Given New $386.00 Price Target at The Goldman Sachs Group**
- Source: MarketBeat | 20260106T145111 | Bullish | Relevance: 100%
- The Goldman Sachs Group has raised its price target for JPMorgan Chase & Co. (NYSE:JPM) from $354.00 to $386.00, maintaining a "buy" rating and implying a 16.21% upside. This follows JPMorgan's recent earnings beat with an EPS of $5.07 and revenue of $47.12 billion. While analyst consensus is currently "Hold" with an average target of $334.57, several firms have also adjusted their price targets for the financial services giant.

**4. JPMorgan (JPM) Gets Fresh Price Target Bump as Barclays Stays Overweight on Big Banks**
- Source: Finviz | 20260106T024222 | Bullish | Relevance: 100%
- Barclays raised its price target on JPMorgan Chase & Co. (NYSE: JPM) to $391 from $342 and maintained an Overweight rating, citing expected continued double-digit earnings growth and bank stock outperformance into 2026. JPMorgan also launched a new advisory unit for select clients, focusing on specialized insights on themes like AI, cybersecurity, and digital assets. This move positions the bank to cater to an investment advisory market expected to grow in 2026 due to technological adoption and geopolitical shifts.

**5. JPMorgan stock hits record intraday high, crosses $900 billion value as banks lead Wall Street rally**
- Source: ts2.tech | 20260105T230820 | Bullish | Relevance: 100%
- JPMorgan Chase & Co. shares rose 2.6% on Monday to $334.04, pushing its market value above $900 billion, as financial stocks led a Wall Street rally ahead of bank earnings and the U.S. jobs report. The bank also launched a new Special Advisory Services unit and received a raised price target from Barclays, further boosting investor confidence.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-06 | Truist Securiti | $331 | $330 | +0% |
| 2026-01-05 | Barclays | $391 | $342 | +14% |
| 2025-12-18 | Truist Securiti | $330 | $319 | +3% |
| 2025-12-17 | Keefe, Bruyette | $363 | $354 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-06 | Truist Securiti | main | Hold |
| 2026-01-05 | Barclays | main | Overweight |
| 2025-12-18 | Truist Securiti | main | Hold |
| 2025-12-17 | Keefe, Bruyette | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.18M) |
| Sells | 5 ($0.45M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-2.2%)
- Blackrock Inc.: 7.7% (+1.6%)
- State Street Corpora: 4.6% (-0.1%)
- Morgan Stanley: 2.4% (-2.3%)
- Geode Capital Manage: 2.2% (+0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 4 raises (avg +5%) could attract flows.
- Momentum building: MRS_10 improving +1.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.78 signals overvaluation risk, limited margin of safety. Forward P/E 15.9x stretched relative to 6% growth. Quality metrics strong (margin 35%). Analyst sentiment positive (4 raises, avg +5%). Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $920.1B |
| Beta | 1.07 |
| 52W Range | $202.16 - $337.25 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.78 |
| Forward P/E | 15.9 |
| Current P/E | 16.8 |
| YoY Growth | 5.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.2% to 1.9% (+1.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >3.0% for momentum thesis). MRS_5 at 1.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.03), confirming momentum. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.95% (CS: 60) | Neutral |
| RSI_14 | 66.9 | Neutral |
| MACD Histogram | 1.03 | Bullish |
| vs SMA20 | 1.044x | Above |
| vs SMA50 | 1.069x | Above |
| vs SMA200 | 1.166x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $334.70
- **Stop Loss:** $322.84 (3.5% risk)
- **Target:** $346.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 111
- **Position Value:** $37,151.70
- **Portfolio %:** 37.15%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-13 (Est: $4.92)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.87 | $5.07 | +4.0% |
| 2025Q2 | $4.47 | $4.96 | +10.9% |
| 2025Q1 | $4.64 | $5.07 | +9.2% |
| 2024Q4 | $4.04 | $4.81 | +19.2% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*